Bellerophon Therapeutics, Inc.
Bellerophon Therapeutics, Inc. (BLPH) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BLPH · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
3
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Bellerophon Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
BLPH insider buying and selling by quarter
BLPH insider selling · BLPH insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
BLPH executive sell shares · BLPH board member insider trading · BLPH insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 13, 2023 | Puissance Capital Management LP 10 percent owner | Sale | 1,076,841 | $112K | Form 4 |
| Jun 7, 2023 | Amin Naseem Director | Award | 47,578 | — | Form 4 |
| Jun 7, 2023 | Puissance Life Science Opportunities Fund VI 10 percent owner | Sale | 134,421 | $112K | Form 4 |
| May 18, 2023 | Kim Bobae VP Reg. Affairs & Quality | Option | 1,022 | $8K | Form 4 |
| May 18, 2023 | Kim Bobae VP Reg. Affairs & Quality | Sale | 9,455 | $95K | Form 4 |
| May 18, 2023 | Kim Bobae VP Reg. Affairs & Quality | Option | 266 | $2K | Form 4 |
| May 18, 2023 | Puissance Life Science Opportunities Fund VI 10 percent owner | Sale | 560,000 | $5.30M⚡ | Form 4 |
| Feb 10, 2023 | Amin Naseem Director | Award | 84,000 | — | Form 4 |
| Dec 9, 2022 | Dekker Martin Director | Other | 7,834 | $7K | Form 4 |
| Dec 9, 2022 | Shah Parag Suresh Director | Other | 7,834 | $7K | Form 4 |
| Dec 9, 2022 | Laccona Nicholas Director | Other | 5,530 | $5K | Form 4 |
| Dec 9, 2022 | Fernandes Peter Director | Other | 9,985 | $9K | Form 4 |
| Dec 31, 2021 | Amin Naseem Director | Award | 39,032 | — | Form 4 |
| Jun 7, 2021 | Puissance Life Science Opportunities Fund VI 10 percent owner | Award | 8,189 | $33K | Form 4 |
| Apr 26, 2021 | Puissance Life Science Opportunities Fund VI 10 percent owner | Award | 609,231 | $2.44M⚡ | Form 4 |
| Mar 31, 2021 | Peacock Jonathan M Director | Award | 15,308 | — | Form 4 |
| Mar 18, 2021 | New Mountain Investments II, LLC 10 percent owner | Sale | 400,000 | $2.19M⚡ | Form 4 |
| Sep 10, 2020 | FARES Wassim Chief Medical Officer | Purchase | 4,000 | $41K | Form 4 |
| Jun 8, 2020 | Wang Theodore T Director | Purchase | 2,600 | $33K | Form 4 |
| Jun 5, 2020 | Wang Theodore T Director | Purchase | 4,986 | $63K | Form 4 |
| May 21, 2020 | Puissance Life Science Opportunities Fund VI 10 percent owner | Award | 1,153,846 | $15.00M⚡ | Form 4 |
| Apr 17, 2020 | Puissance Cross-Border Opportunities III LLC 10 percent owner | Other | 553,250 | — | Form 4 |
| Jan 23, 2020 | Peacock Jonathan M Director | Award | 350,000 | — | Form 4 |
| Nov 25, 2019 | Wang Theodore T Director | Purchase | 7,193 | $3K | Form 4 |
| Nov 22, 2019 | Wang Theodore T Director | Purchase | 1,050 | $394 | Form 4 |
Puissance Capital Management LP
10 percent owner
Date
Oct 13
Shares
1,076,841
Price
$0.10
Value
$112K
Puissance Life Science Opportunities Fund VI
10 percent owner
Date
Jun 7
Shares
134,421
Price
$0.83
Value
$112K
Kim Bobae
VP Reg. Affairs & Quality
Date
May 18
Shares
1,022
Price
$7.50
Value
$8K
Kim Bobae
VP Reg. Affairs & Quality
Date
May 18
Shares
9,455
Price
$10.00
Value
$95K
Puissance Life Science Opportunities Fund VI
10 percent owner
Date
May 18
Shares
560,000
Price
$9.46
Value
$5.30M ⚡
Puissance Life Science Opportunities Fund VI
10 percent owner
Date
Jun 7
Shares
8,189
Price
$4.00
Value
$33K
Puissance Life Science Opportunities Fund VI
10 percent owner
Date
Apr 26
Shares
609,231
Price
$4.00
Value
$2.44M ⚡
New Mountain Investments II, LLC
10 percent owner
Date
Mar 18
Shares
400,000
Price
$5.48
Value
$2.19M ⚡
FARES Wassim
Chief Medical Officer
Date
Sep 10
Shares
4,000
Price
$10.18
Value
$41K
Puissance Life Science Opportunities Fund VI
10 percent owner
Date
May 21
Shares
1,153,846
Price
$13.00
Value
$15.00M ⚡
Puissance Cross-Border Opportunities III LLC
10 percent owner
Date
Apr 17
Shares
553,250
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BLPH insider trading
BLPH insider trades
Bellerophon Therapeutics, Inc. (BLPH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including BLPH. Over the past 12 months, 0 insiders have filed transactions with the SEC. BLPH insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Bellerophon Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BLPH insider trading · 5 questionsThe insiders of Bellerophon Therapeutics, Inc. (BLPH) include executives and directors such as BLPH, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026